Medical Science News

RSS

First realistic 3-D diagram of thalamocortical column in rodent brain

Researchers from the lab of Nobel laureate Bert Sakmann, MD, PhD at the Max Planck Florida Institute (MPFI) are reporting that, using a conceptually new approach and state-of-the-art research tools, they have created the first realistic three-dimensional diagram of a thalamocortical column in the rodent brain.

8 Dec 2011

Intensive maternal care during infancy promotes effect of NPY in brain

Neuropeptide Y (NPY) is the most abundant peptide hormone of the central nervous system. It is involved in various processes including stress management, the development of anxiety behaviour and body weight regulation. A collaborative research group including scientists from the Max Planck Institute for Medical Research in Heidelberg has demonstrated using mice that intensive maternal care during infancy promotes the effect of NPY in the brain.

8 Dec 2011

Researchers sequence entire transcriptome of mouse neural retina

The population of Eric Morrow's seminar "Neurogenetics and Disease" comprises mainly undergraduates who were skipping down the halls of their elementary schools when the first drafts of human genome sequences were published. When Morrow, assistant professor of biology, recently asked the class how to find the mutation behind a disease, a hand shot up in the back of the class to signal the answer: "Sequence the patient's genome."

8 Dec 2011

“Gold standard” stem cells for clinical testing

British researchers claim to have created stem cells of a “gold standard” quality that could lead to a new wave of treatments for degenerative diseases. Taken from human embryos, they could be available to researchers before the end of next year for eventual use in clinical trials, The Daily Telegraph reported Tuesday.

7 Dec 2011

Next generation personal genomic testing now widely available

The era of widely available next generation personal genomic testing has arrived and with it the ability to quickly and relatively affordably learn the sequence of your entire genome. This would include what is referred to as the "exome," your complete set of protein-coding sequences.

7 Dec 2011

New cell formation after arterial injury increases risk of further heart attacks

"After an arterial injury, the inner layer of cells in the artery begins to regrow. In the long term, this usually causes more harm than good", says Maria Gomez.

7 Dec 2011

Pycnogenol enhances mental performance

Keeping your brain in shape-no sweat. Health-conscious consumers may not realize that supplementing a healthy diet is just as important to maintaining mental performance as it is to maintaining six-pack abs.

7 Dec 2011

Relaxin improves poor blood flow and kidney function in a rat model of PKD

After a four-week course of the vasodilator hormone relaxin, kidney function and blood flow immediately improved in lab rats genetically altered to model polycystic kidney disease (PKD), a life-threatening genetic disorder, according to research presented on Dec. 6 at the American Society for Cell Biology Annual Meeting in Denver.

7 Dec 2011

New research on bed bug's ability to withstand genetic bottleneck of inbreeding

New research on the bed bug's ability to withstand the genetic bottleneck of inbreeding, announced today at the American Society of Tropical Medicine and Hygiene (ASTMH) annual meeting, provides new clues to explain the rapidly growing problem of bed bugs across the United States and globally.

7 Dec 2011

Scientists help uncover evolutionary history of TAS2R38 bitter taste receptor gene

Long the bane of picky eaters everywhere, broccoli's taste is not just a matter of having a cultured palate; some people can easily taste a bitter compound in the vegetable that others have difficulty detecting. Now a team of Penn researchers has helped uncover the evolutionary history of one of the genes responsible for this trait.

7 Dec 2011

Researchers identify likely cause of essential tremor

Researchers from the CHUQ research center and Universit- Laval have discovered the likely cause of essential tremor (ET), a neurological disorder that affects more than 10 million North Americans.

7 Dec 2011

Web-based video game players contribute to analysis of DNA sequences

Thousands of video game players have helped significantly advance our understanding of the genetic basis of diseases such as Alzheimer's, diabetes and cancer over the past year. They are the users of a web-based video game developed by Dr. J-r-me Waldispuhl of the McGill School of Computer Science and collaborator Mathieu Blanchette.

7 Dec 2011

King's College London submits first clinical grade xeno-free hES cell lines to the UKSCB

Stem cell scientists at King's College London will announce they have submitted to the UK Stem Cell Bank (UKSCB) their first clinical grade human embryonic stem (hES) cell lines that are free from animal-derived products, known as 'xeno-free' stem cells.

7 Dec 2011

Supercomputer simulations give insight into proteins involved in drug detoxification

Supercomputer simulations at the Department of Energy's Oak Ridge National Laboratory are giving scientists unprecedented access to a key class of proteins involved in drug detoxification.

7 Dec 2011

Evaluation method supports soy as high-quality protein

The importance of protein in the human body is undeniable. However, the idea of what makes a protein a "quality protein" has not been as easy to determine. A new study from the Journal of Agriculture and Food Chemistry takes a closer look at the criteria for determining the quality of a protein.

7 Dec 2011

SG Austria, Nuvilex use live cell encapsulation technology and treat diabetes in animal model

Nuvilex, Inc. announced today their affiliate SG Austria and partners have successfully treated diabetes in an established, recognized animal model utilizing live encapsulated cells.

7 Dec 2011

Pretreatment fasting glucose could block breast cancer progression

An increasing understanding of molecular pathways that regulate breast and colorectal cancer development and progression has produced new therapeutic agents, including the biologic agents trastuzumab, bevacizumab, and cetuximab. Identifying the indicators that are likely to predict which patients will achieve the best response to these agents represents a major challenge for contemporary oncologists.

7 Dec 2011